The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma

被引:0
|
作者
Pilotti S. [1 ]
Della Torre G. [2 ]
Mezzelani A. [1 ]
Tamborini E. [1 ]
Azzarelli A. [3 ]
Sozzi G. [2 ]
Pierotti M.A. [2 ]
机构
[1] Dept. of Pathology and Cytopathology, Ist. Naz. per lo Studio e la Cura, 1-20133 Milano, Via G. Venezian
[2] Department of Experimental Oncology, Ist. Naz. per lo Studio e la Cura, 1-20133 Milano, Via G. Venezian
[3] Dept. of Surg. of Soft Tissue Tumors, Ist. Naz. per lo Studio e la Cura, 1-20133 Milano, Via G. Venezian
关键词
CDK4; Differential diagnosis; Lipoma; Liposarcoma lipoma-like; MDM2;
D O I
10.1054/bjoc.1999.1090
中图分类号
学科分类号
摘要
Ordinary lipomas are cytogenetically characterized by a variety of balanced rearrangements involving chromosome segment 12q13-15, whereas well differentiated liposarcomas (WDL) show supernumerary ring and giant marker chromosomes, known to contain amplified 12q sequences. The tight correlation between the presence of ring chromosomes and both amplification and overexpression of MDM2 and CDK4 genes suggests the exploration of the possibility that immunocytochemistry (ICC) might assist in the differential diagnosis of lipoma-like well differentiated liposarcomas (LL-WDL) and large deep-seated lipomas (LDSL). For this purpose, 21 cases of the former and 19 cases of the latter tumours were analysed by ICC and, according to the availability of material, by molecular and cytogenetic approaches. All lipomas displayed a null MDM2/CDK4 phenotype, whereas all LL-WDL showed MDM2/CDK4 or CDK4 phenotypes. Southern blot analysis performed on 16 suitable cases, complemented by fluorescence in situ hybridization and classical cytogenetic analysis in 11 cases, was consistent with, and further supported the immunophenotyping data. In conclusion, MDM2/CDK4 product-based immunophenotyping appears to represent a valuable method for the categorization of arguable LDSL. (C) 2000 Cancer Research Campaign.
引用
下载
收藏
页码:1271 / 1275
页数:4
相关论文
共 50 条
  • [21] Overdiagnosis of atypical lipomatous tumors/well-differentiated liposarcomas by morphological diagnosis using only HE stained specimens: a case–control study with MDM2/CDK4 immunostaining and MDM2/CDK4 fluorescence in situ hybridization
    Kentaro Nomura
    Masato Tomita
    Kishio Kuroda
    Masakazu Souda
    Ko Chiba
    Akihiko Yonekura
    Makoto Osaki
    BMC Cancer, 24 (1)
  • [22] Castleman Disease with MDM2/CDK4 Protein Expression: a Potential Mimic of Inflammatory Variant of Liposarcoma with Significant Consequences
    Georgantzoglou, Natalia
    Baker, Michael
    Liu, Xiaoying
    Kerr, Darcy A.
    Linos, Konstantinos
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (07) : 753 - 759
  • [23] MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification
    Brisson, Melanie
    Kashima, Takeshi
    Delaney, David
    Tirabosco, Roberto
    Clarke, Andrew
    Cro, Suzie
    Flanagan, Adrienne M.
    O'Donnell, Paul
    SKELETAL RADIOLOGY, 2013, 42 (05) : 635 - 647
  • [24] A phase 2 trial of the CDK4 inhibitor dalpiciclib in well-differentiated or dedifferentiated liposarcoma
    Liu, Zengjun
    Liu, Mengyao
    Xu, Jing
    Hu, Wenyu
    Zhang, Hui
    Tao, Rongjie
    Li, Xinyu
    Cha, Lichao
    Cui, Jinfang
    Zhao, Junkai
    Fu, Heng
    Fan, Chunxiang
    Tian, Lantian
    Qiu, Fabo
    Zhu, Dongyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes -: A comparative analysis of 559 soft tissue neoplasms with genetic data
    Binh, MBN
    Sastre-Garau, X
    Guillou, L
    de Pinieux, G
    Terrier, P
    Lagacé, R
    Aurias, A
    Hostein, I
    Coindre, JM
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (10) : 1340 - 1347
  • [26] Correlating MDM2 and CDK4 Amplification Levels in Dedifferentiated Liposarcoma (DDLS) with Tumor Behavior and Patient Outcome
    Liu, Y.
    Ricciotti, R.
    Hoch, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S30 - S30
  • [27] MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors? A New Perspective
    Clay, Michael R.
    Martinez, Anthony P.
    Weiss, Sharon W.
    Edgar, Mark A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (12) : 1647 - 1652
  • [28] Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma
    Segura-Sanchez, Juan
    Gonzalez-Campora, Ricardo
    Pareja-Megia, Maria Jesus
    Garcia-Escudero, Antonio
    Galera-Ruiz, Hugo
    Lopez-Beltran, Antonio
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4937 - 4942
  • [29] MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 geneamplification
    Mélanie Brisson
    Takeshi Kashima
    David Delaney
    Roberto Tirabosco
    Andrew Clarke
    Suzie Cro
    Adrienne M. Flanagan
    Paul O’Donnell
    Skeletal Radiology, 2013, 42 : 635 - 647
  • [30] HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon
    Italiano, Antoine
    Bianchini, Laurence
    Keslair, Frederique
    Bonnafous, Stephanie
    Cardot-Leccia, Nathalie
    Coindre, Jean-Michel
    Dumollard, Jean-Marc
    Hofman, Paul
    Leroux, Agnes
    Mainguene, Claire
    Peyrottes, Isabelle
    Ranchere-Vince, Dominique
    Terrier, Philippe
    Tran, Albert
    Gual, Philippe
    Pedeutour, Florence
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2233 - 2241